Literature DB >> 8912808

Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I.

J A Di Battista1, S Doré, J Martel-Pelletier, J P Pelletier.   

Abstract

Prostaglandin E2 (PGE2) stimulates collagen gene promoter activity in transfected human chondrocytes though no canonical cyclic AMP (cAMP) response element has been yet identified. Human insulin-like growth factor-1 (IGF-1) induces an increase in collagen type II expression and synthesis in chondrocytes. Since our preliminary data suggested that PGE2 can stimulate IGF-1 release from human articular chondrocytes, we examined whether the eicosanoid could influence collagen synthesis and whether the effect was mediated by IGF-1. Incubation of primary cultures of human articular chondrocytes with increasing concentrations of PGE2 resulted in a dose-dependent (ANOVA, F= 51.62, P < 0.0001, n = 5) and saturable increase in the synthesis and release of IGF-1 and expression of IGF-1 mRNA. At relatively low concentrations (30 pmol/1 to 30 nmol/l), PGE2 stimulated an increase in the incorporation of [3H]proline into collagenase digestible protein (CDP) (P < 0.01, n = 5) whereas at high levels (300 nmol/l to 3 micromol/l) of the eicosanoid, incorporation diminished precipitously. Human IGF-1 mimicked the effects of low PGE2 concentrations by stimulating in a dose-dependent (ANOVA, F= 31.65, P < 0.001, n = 3) and saturable fashion the incorporation of [3H]proline into CDP although the magnitude of the response induced by IGF-1 was far greater (3.5-fold). An IGF-1 receptor blocking antibody completely abrogated the IGF-1 induced response suggesting that the effect was specifically IGF-1 receptor mediated. Furthermore, the PGE2-induced increase in [3H]proline incorporation into CDP was inhibited (63%, P < 0.001, n = 7) by the addition to the culture medium of an anti-IGF-1 antibody. We conclude that PGE2 may act as a secretagogue of IGF-1 and that the latter growth factor may mediate, via an autocrine loop and the IGF-1 receptor, at least some of the anabolic effects of the eicosanoid on cartilage metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912808     DOI: 10.1016/0303-7207(96)03887-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Celecoxib inhibits nitric oxide production in chondrocytes of ligament-damaged osteoarthritic rat joints.

Authors:  Kenta Matsuda; Shigeru Nakamura; Takashi Matsushita
Journal:  Rheumatol Int       Date:  2006-01-26       Impact factor: 2.631

2.  Prostacyclin regulates bone growth via the Epac/Rap1 pathway.

Authors:  Michele R Hutchison; Perrin C White
Journal:  Endocrinology       Date:  2014-11-18       Impact factor: 4.736

3.  Prostaglandin E2 and prostaglandin F2α differentially modulate matrix metabolism of human nucleus pulposus cells.

Authors:  Nam V Vo; Gwendolyn A Sowa; James D Kang; Christopher Seidel; Rebecca K Studer
Journal:  J Orthop Res       Date:  2010-10       Impact factor: 3.494

Review 4.  COX-2, NO, and cartilage damage and repair.

Authors:  A R Amin; M Dave; M Attur; S B Abramson
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

5.  "In vitro" differences among (R) and (S) enantiomers of profens in their activities related to articular pathophysiology.

Authors:  A M Panico; V Cardile; B Gentile; F Garufi; S Avondo; S Ronsisvalle
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

6.  Integrative structural biomechanical concepts of ankylosing spondylitis.

Authors:  Alfonse T Masi; Kalyani Nair; Brian J Andonian; Kristina M Prus; Joseph Kelly; Jose R Sanchez; Jacqueline Henderson
Journal:  Arthritis       Date:  2011-12-18

7.  The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man.

Authors:  Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Arthritis Res       Date:  2001-11-02

8.  The Role of Prostaglandins and COX-Enzymes in Chondrogenic Differentiation of ATDC5 Progenitor Cells.

Authors:  Marjolein M J Caron; Pieter J Emans; Kathleen Sanen; Don A M Surtel; Andy Cremers; Daan Ophelders; Lodewijk W van Rhijn; Tim J M Welting
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

9.  Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.

Authors:  Janet E Jeffrey; Richard M Aspden
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.

Authors:  Elena V Tchetina; John A Di Battista; David J Zukor; John Antoniou; A Robin Poole
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.